Genmab — Maj 2018

[royal]

Ok. Tak Bulder.

[E_L]

Daratumumab and Elotuzumab: Potential mAb Therapies for Multiple Myeloma https://www.cancertherapyadvisor.com/multiple-myeloma/multiple-myeloma-daratumumab-elotuzumab-potential-mab-therapy/article/768206/

[E_L]

Genmab (GMXAY) Presents At 2018 UBS Global Healthcare Conference - Slideshow - https://seekingalpha.com/article/4176638-genmab-gmxay-presents-2018-ubs-global-healthcare-conference-slideshow

[E_L]

on p19 - Complete recruitment phase III SC Ofa relapsing MS studies- is checked; confirming this is fully recruited

[E_L]

that last clinicaltrial update must have been a mistake, as Bulder suggested

[Bulder]

I'll write to Ms Gravesen and ask

[Bulder]

Sometimes things happen fast: "This may be an error (ct.gov can sometimes experience incorrect updates.
Let me ask my team here and if you don’t hear from me it is an error. Otherwise I will come back to you.

Both NVS and Genmab are still anticipating data readouts in 2019.
Yours Rachel"
I'll inform the chat if it's not an error.

[JKY_VH]

Tak Bulder og god morgen:-)

[bibob]

God morgen. :-). Og tak Bulder. Hun er hurtig hende Rachel.

[Helge_LarsenPI-redaktør]

God morgen.

[polle1]

God morgen

[Her_for_at_lære]

God morgen

[henrik48]

God morgen - det var skønt at høre FS i går

[E_L]

thanks Bulder (and Rachel )

[gentogen]

Top fint med FS. Intervieweren var så optaget af at spørge til kurs 2000 igen og igen (hvornår, hvorfor etc.), at hun slet ikke opfattede, at FS allerede er langt videre....

[Bulder]

kurs 3000?

[gentogen]

Så har du nok ikke sagt for meget

[Sukkeralf]

$ kurs
6,36

[nik_hs1990]

Ja skønt at dollarkursen er kravlet pænt op de seneste måneder

[polle1]

Helt ekstrem lille omsætning !